OmniAb (OABI) Non Operating Investment Income (2022)
OmniAb (OABI) reported Non Operating Investment Income of $1.1 million for Q3 2022, up 267.13% on a QoQ basis from $297047.0 in Q2 2022.
OmniAb (OABI) has 1 years of Non Operating Investment Income data on file, last reported at $1.1 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 235,807.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 230,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 297,047.00 |
| Jun 30, 2022 | 297,047.00 |
| Mar 31, 2022 | 51,285.00 |
| Mar 31, 2022 | 51,285.00 |